Sunshine Biopharma (SBFM) Asset Utilization Ratio (2018 - 2026)

Sunshine Biopharma has reported Asset Utilization Ratio for 9 years, with the latest figure at 1.22 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio rose 0.89% year-over-year to 1.22; the trailing twelve-month figure through Mar 2026 stood at 1.22 (up 0.89% YoY), and the FY2025 full-year result was 1.2, down 0.59% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 1.22, up from 1.18 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 1.22 in Q1 2026, with the low at 0.01 in Q3 2022.
• Historically, Asset Utilization Ratio has averaged 0.75 across 5 years, with a median of 0.9 in 2024.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio slumped 85.06% — and 2023, when it soared 6027.84%.
• Sunshine Biopharma's Asset Utilization Ratio stood at 0.12 in 2022, then soared by 606.75% to 0.88 in 2023, then jumped by 31.33% to 1.15 in 2024, then advanced by 2.5% to 1.18 in 2025, then grew by 3.76% to 1.22 in 2026.
• The last three Asset Utilization Ratio figures came in at 1.22 (Q1 2026), 1.18 (Q4 2025), and 1.18 (Q3 2025), per Business Quant data.